
DARZALEX (Daratumumab)
DARZALEX is indicated for the treatment of adult patients with multiple myeloma: in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for…
DARZALEX is indicated for the treatment of adult patients with multiple myeloma: in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for…
DARZALEX FASPRO is a combination of daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase, indicated for the treatment of adult patients with: multiple…
Infliximab is a tumor necrosis factor (TNF) blocker indicated for: Crohn’s Disease: reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with…
REMICADE is a tumor necrosis factor (TNF) blocker indicated for: Crohn’s Disease: reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with…
RYBREVANT is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2022. All Rights Reserved.